Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Mitra Pedagang Indonesia Tbk. (MPIX) vs Organon Pharma Indonesia Tbk. (SCPI)

Mitra Pedagang Indonesia Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Mitra Pedagang Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Mitra Pedagang Indonesia Tbk. diperdagangkan di Rp127 (kapitalisasi pasar 184,38 M, volume 24 jam 62,37 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Mitra Pedagang Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

MPIXSCPI
Kapitalisasi Pasar
184,38 M104,4 M
Volume
62,37 jt
Lot
623,69 rb
Perputaran
7,9 M
Harga Rata-rata
126,63
Nilai Transaksi
7,9 M
Harga Ekuilibrium Indikatif
127
Volume Ekuilibrium Indikatif
11,69 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MPIX
Lihat detail
SCPI
Lihat detail

Tentang Mitra Pedagang Indonesia Tbk.

PT Mitra Pedagang Indonesia Tbk (theCompany) was established based on Deed No.2 dated July,2019 made before Notary Ika Anggraini,S.H.,M.Kn.in Malang. The Company started its commercial activities since 2019, by operating under the trademarks of MPStore. The Controlling Shareholder and Beneficial Owner of the Company is Abdul Muidz, through PT Madura Prima Investama, with direct ownership of the Company's shares.

Selengkapnya di halaman MPIX

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI